|
DAXX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.17709999525317E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.56390003567009E-09 |
| Normal-vs-Stage2 |
3.836400E-03 |
| Normal-vs-Stage3 |
2.34339999960476E-07 |
| Normal-vs-Stage4 |
5.92609999999771E-05 |
| Stage1-vs-Stage2 |
3.726800E-01 |
| Stage1-vs-Stage3 |
3.493400E-01 |
| Stage1-vs-Stage4 |
9.776800E-01 |
| Stage2-vs-Stage3 |
1.608750E-01 |
| Stage2-vs-Stage4 |
4.786400E-01 |
| Stage3-vs-Stage4 |
5.234000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.16439999759055E-08 |
| Normal-vs-AfricanAmerican |
6.177300E-04 |
| Normal-vs-Asian |
1.917160E-03 |
| Caucasian-vs-AfricanAmerican |
8.641200E-01 |
| Caucasian-vs-Asian |
4.199600E-02 |
| AfricanAmerican-vs-Asian |
2.565600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.422950E-04 |
| Normal-vs-Female |
7.46560036013477E-10 |
| Male-vs-Female |
7.164500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.32860000001678E-07 |
| Normal-vs-Age(41-60Yrs) |
2.38480000191998E-08 |
| Normal-vs-Age(61-80Yrs) |
4.53670000011286E-07 |
| Normal-vs-Age(81-100Yrs) |
7.252000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.666800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.345600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.776200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.092600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.181000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.861600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.225760E-02 |
| Classical-VS-Follicular |
9.274400E-02 |
| Classical-VS-Other |
4.670200E-01 |
| Classical-VS-Normal |
2.26950000015158E-07 |
| Tall-VS-Follicular |
3.050600E-01 |
| Tall-VS-Other |
6.006800E-01 |
| Tall-VS-Normal |
8.37089999539131E-08 |
| Follicular-VS-Other |
9.729800E-01 |
| Follicular-VS-Normal |
2.43470000049761E-07 |
| Other-VS-Normal |
9.563100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.18669999999077E-06 |
| Normal-vs-N1 |
6.41959999603259E-08 |
| N0-vs-N1 |
5.285900E-02 |
|
|
